Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT02223403
Eligibility Criteria:
Inclusion Criteria:
* Local institutional beneficiaries between the ages of 18 and 80
* Documentation of left ventricular systolic dysfunction with ejection fraction \< 40% by any modality within the past six months
* Documentation of New York Heart Association class II or III status.
Exclusion Criteria:
* \> 80 years of age
* Unable to adequately or safely perform treadmill exercise
* Pulmonary disease deemed significant enough to be a limitation to exercise
* Greater than moderate stenotic or regurgitant valvular heart disease
* Presence of atrial fibrillation or other uncontrolled arrhythmias
* Uncompensated heart failure
* Continuously paced rhythms
* Pregnant females
* Chronic nitroglycerine use (oral isosorbide di or mono-nitrate, or topical nitroglycerine)
* Phosphodiesterase inhibitor (sildenafil or tadalafil) use within a week
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02223403
Study Brief:
Protocol Section:
NCT02223403